Welcome!

News Feed Item

First Licensing Deals for Stem Cell Company Accellta

First licensing deals for stem cell company Accellta- this month the company announced that it granted worldwide, non-exclusive rights to Miltenyi Biotec to use one of Accellta’s patents in manufacturing and commercialization of Miltenyi Biotec’s proprietary medium for stem cell cultivation. Miltenyi Biotec is active worldwide and is one of the innovative leaders in products, services and clinical applications for biomedical research and cell therapy.

Several months ago, Accellta granted a similar license to Japanese nutrition and health giant, Ajinomoto. The non-exclusive license includes manufacturing and marketing rights of the medium in Japan, for both research and commercial applications. Ajinomoto has operations in 26 countries and encompasses a wide range of food and nutrition products, amino acids, chemicals and pharmaceuticals, with annual revenues exceeding USD 11 billion.

Accellta offers a range of revolutionary solutions for better affordability and quality of stem cell culturing and for developing disease models. The company was established in November 2012 by the Technion and AMIT (the Alfred Mann Institute at the Technion); its unique solutions are the result of over 15 years of pioneering research and development at the Stem Cell Center in the Rappaport Faculty of Medicine at the Technion- Israel Institute of Technology.

"The licensing deals leverage Accellta's intellectual property and allow us to offer our unique solutions to stem cell scientists and researchers worldwide, the number of which is estimated at over 100,000," says Accellta Chairman, Dr. Zeev Gilkis. "We believe these deals pave the way for more collaborations with the biomedical industry."

Since it was established, Accellta invested in creating strategic business collaborations and building physical infrastructure for clinical grade cell manufacturing. Recently it completed the construction of a state-of-the-art manufacturing facility, which will be used for industrial scale manufacturing of clinical-grade stem cells. The complex, which will serve the emerging regenerative therapy industry, is located in Haifa, Israel and includes 550 sqm of clean rooms, QC laboratories, R&D laboratories and offices.

According to Dr. Michal Amit, one of the world pioneers in stem cell research and Accellta's R&D manager, "The new manufacturing facility, together with Accellta's innovative solutions, allow both stem cell companies and research labs to culture higher quality cells in a faster, more uniform, and much more cost-effective manner."

Among Accellta's proprietary solutions: MAXELLS- a proprietary technology for cost-effective industrialization of stem cell manufacturing. Maxells uses suspension culturing and delivers unparalleled scalability and quality; SINGLES- a breakthrough technology for simple and effective culturing of stem cells as single-cells in suspension, which serves as a platform for genetic manipulation and provides enhanced uniformity and purity. In addition Accellta markets several stem cell lines and unique feeder cells.

Nowadays Accellta is focused on creating strategic partnerships with Biopharma companies and Stem Cell companies for developing economic manufacturing processes for cell products and for developing model systems for new drug screening and testing. In the future the company will also enter the market of regenerative medicine and develop therapies for currently incurable diseases.

About Accellta

Accellta develops, manufactures and markets a range of revolutionary solutions for better affordability and quality of stem cell culturing. Accellta's technologies are the result of over 15 years of pioneering research and development at the Stem Cell Center in the Technion’s Rappaport Faculty of Medicine. Accellta is a subsidiary of the Alfred Mann Institute at the Technion (AMIT) and operates a state-of-the-art manufacturing facility, laboratories and offices in Haifa, Israel. www.accellta.com

About AMIT

AMIT- Alfred Mann Institute at the Technion is the Technion hub for biomedical innovation, active since 2006, it supports the development and commercialization of exceptional bio-medical technologies conceived by Technion researchers. The institute is chaired and funded by American Billionaire and Philanthropist Dr. Alfred E. Mann. AMIT owns three startup companies- Accellta, Sealantis and Sanoculis. www.amitechnion.com

More Stories By Business Wire

Copyright © 2009 Business Wire. All rights reserved. Republication or redistribution of Business Wire content is expressly prohibited without the prior written consent of Business Wire. Business Wire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
You think you know what’s in your data. But do you? Most organizations are now aware of the business intelligence represented by their data. Data science stands to take this to a level you never thought of – literally. The techniques of data science, when used with the capabilities of Big Data technologies, can make connections you had not yet imagined, helping you discover new insights and ask new questions of your data. In his session at @ThingsExpo, Sarbjit Sarkaria, data science team lead ...
Extracting business value from Internet of Things (IoT) data doesn’t happen overnight. There are several requirements that must be satisfied, including IoT device enablement, data analysis, real-time detection of complex events and automated orchestration of actions. Unfortunately, too many companies fall short in achieving their business goals by implementing incomplete solutions or not focusing on tangible use cases. In his general session at @ThingsExpo, Dave McCarthy, Director of Products...
WebRTC is bringing significant change to the communications landscape that will bridge the worlds of web and telephony, making the Internet the new standard for communications. Cloud9 took the road less traveled and used WebRTC to create a downloadable enterprise-grade communications platform that is changing the communication dynamic in the financial sector. In his session at @ThingsExpo, Leo Papadopoulos, CTO of Cloud9, discussed the importance of WebRTC and how it enables companies to focus...
Amazon has gradually rolled out parts of its IoT offerings in the last year, but these are just the tip of the iceberg. In addition to optimizing their back-end AWS offerings, Amazon is laying the ground work to be a major force in IoT – especially in the connected home and office. Amazon is extending its reach by building on its dominant Cloud IoT platform, its Dash Button strategy, recently announced Replenishment Services, the Echo/Alexa voice recognition control platform, the 6-7 strategic...
Aspose.Total for .NET is the most complete package of all file format APIs for .NET as offered by Aspose. It empowers developers to create, edit, render, print and convert between a wide range of popular document formats within any .NET, C#, ASP.NET and VB.NET applications. Aspose compiles all .NET APIs on a daily basis to ensure that it contains the most up to date versions of each of Aspose .NET APIs. If a new .NET API or a new version of existing APIs is released during the subscription peri...
Verizon Communications Inc. (NYSE, Nasdaq: VZ) and Yahoo! Inc. (Nasdaq: YHOO) have entered into a definitive agreement under which Verizon will acquire Yahoo's operating business for approximately $4.83 billion in cash, subject to customary closing adjustments. Yahoo informs, connects and entertains a global audience of more than 1 billion monthly active users** -- including 600 million monthly active mobile users*** through its search, communications and digital content products. Yahoo also co...
Ixia (Nasdaq: XXIA) has announced that NoviFlow Inc.has deployed IxNetwork® to validate the company’s designs and accelerate the delivery of its proven, reliable products. Based in Montréal, NoviFlow Inc. supports network carriers, hyperscale data center operators, and enterprises seeking greater network control and flexibility, network scalability, and the capacity to handle extremely large numbers of flows, while maintaining maximum network performance. To meet these requirements, NoviFlow in...
As companies gain momentum, the need to maintain high quality products can outstrip their development team’s bandwidth for QA. Building out a large QA team (whether in-house or outsourced) can slow down development and significantly increases costs. This eBook takes QA profiles from 5 companies who successfully scaled up production without building a large QA team and includes: What to consider when choosing CI/CD tools How culture and communication can make or break implementation
"There's a growing demand from users for things to be faster. When you think about all the transactions or interactions users will have with your product and everything that is between those transactions and interactions - what drives us at Catchpoint Systems is the idea to measure that and to analyze it," explained Leo Vasiliou, Director of Web Performance Engineering at Catchpoint Systems, in this SYS-CON.tv interview at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York Ci...
Redis is not only the fastest database, but it is the most popular among the new wave of databases running in containers. Redis speeds up just about every data interaction between your users or operational systems. In his session at 19th Cloud Expo, Dave Nielsen, Developer Advocate, Redis Labs, will share the functions and data structures used to solve everyday use cases that are driving Redis' popularity.
UpGuard has become a member of the Center for Internet Security (CIS), and will continue to help businesses expand visibility into their cyber risk by providing hardening benchmarks to all customers. By incorporating these benchmarks, UpGuard's CSTAR solution builds on its lead in providing the most complete assessment of both internal and external cyber risk. CIS benchmarks are a widely accepted set of hardening guidelines that have been publicly available for years. Numerous solutions exist t...
"We're bringing out a new application monitoring system to the DevOps space. It manages large enterprise applications that are distributed throughout a node in many enterprises and we manage them as one collective," explained Kevin Barnes, President of eCube Systems, in this SYS-CON.tv interview at DevOps at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York City, NY.
Choosing the right cloud for your workloads is a balancing act that can cost your organization time, money and aggravation - unless you get it right the first time. Economics, speed, performance, accessibility, administrative needs and security all play a vital role in dictating your approach to the cloud. Without knowing the right questions to ask, you could wind up paying for capacity you'll never need or underestimating the resources required to run your applications.
SYS-CON Events announced today that LeaseWeb USA, a cloud Infrastructure-as-a-Service (IaaS) provider, will exhibit at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. LeaseWeb is one of the world's largest hosting brands. The company helps customers define, develop and deploy IT infrastructure tailored to their exact business needs, by combining various kinds cloud solutions.
Adding public cloud resources to an existing application can be a daunting process. The tools that you currently use to manage the software and hardware outside the cloud aren’t always the best tools to efficiently grow into the cloud. All of the major configuration management tools have cloud orchestration plugins that can be leveraged, but there are also cloud-native tools that can dramatically improve the efficiency of managing your application lifecycle. In his session at 18th Cloud Expo, ...